HuGE Literature Finder
|
||
Records 1-22
|
Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.
BMC urology 2017 Jan 17 (1): 1. Kuzman James A, Stenehjem David D, Merriman Joseph, Agarwal Archana M, Patel Shiven B, Hahn Andrew W, Alex Anitha, Albertson Dan, Gill David M, Agarwal Neer |
|
FCGR Polymorphisms Influence Response to IL-2 in Metastatic Renal Cell Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Oct . Erbe Amy K, Wang Wei, Goldberg Jacob, Gallenberger Mikayla, Kim KyungMann, Carmichael Lakeesha, Hess Dustin, Mendonca Eneida A, Song Yiqiang, Hank Jacquelyn A, Cheng Su-Chun, Signoretti Sabina, Atkins Michael, Carlson Alexander, Mier James W, Panka David J, McDermott David F, Sondel Paul |
|
Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2.
Cancer immunology, immunotherapy : CII 2016 Sep . Wang Wei, Erbe Amy K, Gallenberger Mikayla, Kim KyungMann, Carmichael Lakeesha, Hess Dustin, Mendonca Eneida A, Song Yiqiang, Hank Jacquelyn A, Cheng Su-Chun, Signoretti Sabina, Atkins Michael, Carlson Alexander, Weiss Jonathan M, Mier James, Panka David, McDermott David F, Sondel Paul |
|
Clinical significance of IL-2 and IL-10 gene polymorphisms and serum levels in patients with basal-cell carcinoma.
Biomarkers in medicine 2015 Nov . Sobjanek Micha?, Zab?otna Monika, Bie? Ewa, Gle? Jolanta, Soko?owska-Wojdy?o Ma?gorzata, Ruckemann-Dziurdzi?ska Katarzyna, Nowicki Rom |
|
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
The Prostate 2015 Sep 75 (13): 1403-18. Winchester Danyelle A, Till Cathee, Goodman Phyllis J, Tangen Catherine M, Santella Regina M, Johnson-Pais Teresa L, Leach Robin J, Xu Jianfeng, Zheng S Lilly, Thompson Ian M, Lucia M Scott, Lippmann Scott M, Parnes Howard L, Dluzniewski Paul J, Isaacs William B, De Marzo Angelo M, Drake Charles G, Platz Elizabeth |
|
Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.
Cellular oncology (Dordrecht) 2014 Feb 37 (1): 29-39. Ribeiro Ilda Patrícia, Marques Francisco, Caramelo Francisco, Pereira João, Patrício Miguel, Prazeres Hugo, Ferrão José, Julião Maria José, Castelo-Branco Miguel, de Melo Joana Barbosa, Baptista Isabel Poiares, Carreira Isabel Marqu |
|
Multi-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver disease.
PloS one 2013 8 (7): e65982. Chen Qing-Rong, Braun Rosemary, Hu Ying, Yan Chunhua, Brunt Elizabeth M, Meerzaman Daoud, Sanyal Arun J, Buetow Kenne |
|
Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese.
International journal of cancer. Journal international du cancer 2012 Feb 130 (3): 671-6. Dai Juncheng, Hu Zhibin, Dong Jing, Xu Lin, Pan Shiyang, Jiang Yue, Jin Guangfu, Chen Yijiang, Shen Hongbi |
|
Interaction between functional polymorphic variants in cytokine genes, established risk factors and susceptibility to basal cell carcinoma of skin.
Carcinogenesis 2011 Dec 32 (12): 1849-54. Rizzato Cosmeri, Canzian Federico, Rudnai Peter, Gurzau Eugen, Stein Angelika, Koppova Kvetoslava, Hemminki Kari, Kumar Rajiv, Campa Danie |
|
Education, tobacco smoking, alcohol consumption, and IL-2 and IL-6 gene polymorphisms in the survival of head and neck cancer.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2011 Oct 44 (10): 1006-12. López R V M, Zago M A, Eluf-Neto J, Curado M P, Daudt A W, da Silva-Junior W A, Zanette D L, Levi J E, de Carvalho M B, Kowalski L P, Abrahão M, de Góis-Filho J F, Boffetta P, Wünsch-Filho |
|
Interleukin-2 -330T>G genetic polymorphism associates with prognosis following surgery for thoracic esophageal squamous cell cancer.
Annals of surgical oncology 2011 Jul 18 (7): 1995-2002. Motoyama Satoru, Miura Masatomo, Hinai Yudai, Maruyama Kiyotomi, Usami Shuetsu, Yoshino Kei, Nakatsu Toshinobu, Saito Hajime, Minamiya Yoshihiro, Ogawa Jun-Ic |
|
A Large-scale genetic association study of esophageal adenocarcinoma risk.
Carcinogenesis 2010 Jul 31 (7): 1259-63. Liu Chen-Yu, Wu Michael C, Chen Feng, Ter-Minassian Monica, Asomaning Kofi, Zhai Rihong, Wang Zhaoxi, Su Li, Heist Rebecca S, Kulke Matthew H, Lin Xihong, Liu Geoffrey, Christiani David |
|
Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk.
Human heredity 2010 69 (3): 193-201. Pierce Brandon L, Ahsan Habib |
|
Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.
PloS one 2010 5 (8): e12402. Hildebrandt Michelle A T, Komaki Ritsuko, Liao Zhongxing, Gu Jian, Chang Joe Y, Ye Yuanqing, Lu Charles, Stewart David J, Minna John D, Roth Jack A, Lippman Scott M, Cox James D, Hong Waun Ki, Spitz Margaret R, Wu Xife |
|
C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
Journal of the American College of Surgeons 2009 Oct 209 (4): 477-83. Motoyama Satoru, Miura Masatomo, Hinai Yudai, Maruyama Kiyotomi, Usami Shuetsu, Nakatsu Toshinobu, Saito Hajime, Minamiya Yoshihiro, Suzuki Toshio, Ogawa Jun-ic |
|
Role of inflammation gene polymorphisms on pain severity in lung cancer patients.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Oct 18 (10): 2636-42. Reyes-Gibby Cielito C, Spitz Margaret R, Yennurajalingam Sriram, Swartz Michael, Gu Jian, Wu Xifeng, Bruera Eduardo, Shete Sanj |
|
CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
Annals of surgical oncology 2009 Sep 16 (9): 2479-85. Motoyama Satoru, Miura Masatomo, Hinai Yudai, Maruyama Kiyotomi, Usami Shuetsu, Saito Hajime, Minamiya Yoshihiro, Satoh Shigeru, Murata Katsuyuki, Suzuki Toshio, Ogawa Jun-ic |
|
CA9 Gene: Single Nucleotide Polymorphism Predicts Metastatic Renal Cell Carcinoma Prognosis.
The Journal of urology 2009 Jun . Martino MD, Klatte T, Seligson DB, Larochelle J, Shuch B, Caliliw R, Li Z, Kabbinavar FF, Pantuck AJ, Belldegrun AS |
|
Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Jun 18 (6): 1829-40. Van Dyke Alison L, Cote Michele L, Wenzlaff Angie S, Chen Wei, Abrams Judith, Land Susan, Giroux Craig N, Schwartz Ann |
|
Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA.
Carcinogenesis 2009 May 30 (5): 758-62. Ognjanovic Simona, Yuan Jian-Min, Chaptman Ann K, Fan Yunhua, Yu Mimi |
|
Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Jul 17 (7): 1790-9. Hussain Shehnaz K, Madeleine Margaret M, Johnson Lisa G, Du Qin, Malkki Mari, Wilkerson Hui-Wen, Farin Federico M, Carter Joseph J, Galloway Denise A, Daling Janet R, Petersdorf Effie W, Schwartz Stephen |
|
Heterozygosity or homozygosity for 2 HLA class II haplotypes predict favorable outcomes for renal cell carcinoma treated with cytokine therapy.
The Journal of urology 2003 Jun 169 (6): 2084-8. Ellerhorst Julie A, Hildebrand William H, Cavett Joshua W, Fernandez-Vina Marcelo A, Hodges Sherie, Poindexter Nancy, Fischer Harald, Grimm Elizabeth |
- Page last reviewed:Jul 30, 2019
- Page last updated:Nov 14, 2019
- Content source: